Treatment of Morton's neuroma with minimally invasive distal metatarsal metaphyseal osteotomy (DMMO) and percutaneous release of the deep transverse metatarsal ligament (DTML): a case series with minimum two-year follow-up.

Autor: Sato G; Department of Orthopaedics, Rheumatology and Traumatology, State University of Campinas (UNICAMP), Campinas, São Paulo, Brazil.; Instituto Vita, São Paulo, Brazil., Ferreira GF; Instituto Vita, São Paulo, Brazil.; Foot and Ankle Surgery Group, Orthopaedics and Traumatology Unit, Prevent Senior, São Paulo, Brazil.; Minimally Invasive Foot Ankle Society (MIFAS By GRECMIP), Merignac, France., Sevilla D; Department of Orthopaedics and Traumatology, Prevent Senior, São Paulo, Brazil., Oliveira CN; Department of Orthopaedics and Traumatology, Prevent Senior, São Paulo, Brazil., Lewis TL; Guy's and St Thomas' NHS Foundation Trust, London, UK., Dinato MCME; Department of Orthopaedics, Rheumatology and Traumatology, State University of Campinas (UNICAMP), Campinas, São Paulo, Brazil.; Instituto Vita, São Paulo, Brazil., Pereira Filho MV; Instituto Vita, São Paulo, Brazil. miguel.viana.filho@gmail.com.; Foot and Ankle Surgery Group, Orthopaedics and Traumatology Unit, Prevent Senior, São Paulo, Brazil. miguel.viana.filho@gmail.com.
Jazyk: angličtina
Zdroj: International orthopaedics [Int Orthop] 2022 Dec; Vol. 46 (12), pp. 2829-2835. Date of Electronic Publication: 2022 Aug 29.
DOI: 10.1007/s00264-022-05557-0
Abstrakt: Background: The optimal treatment of symptomatic Morton's neuroma remains unclear; conservative methods are sometimes ineffective and neurectomy has significant rates of patient dissatisfaction. The aim of this study was to evaluate the outcome of minimally invasive distal metatarsal metaphyseal osteotomy (DMMO) and percutaneous release of the deep transverse metatarsal ligament (DTML) in patients with Morton's neuroma.
Methods: Between January 2018 and November 2019, 27 patients (29 feet) diagnosed with Morton's neuroma after clinical and radiological evaluation underwent DMMO and percutaneous DTML release. The primary clinical outcomes were pain (VAS) and function (AOFAS score). Secondary outcomes included patient satisfaction, complications, and radiographic outcomes. Patients were followed up for a minimum of two years.
Results: The median age of the participants was 66 years (range 48-79) and the follow-up time was 28 months (24-47). There was a decrease of 5.7 points in the VAS for pain (p < .001) and an increase of 19.9 in AOFAS (p < .001) after the surgical procedure. There was one case of superficial infection and one patient required resection of the neuroma (neurectomy). The majority of patients (89.7%) were satisfied and considered the procedure outcome as excellent or good.
Conclusion: Treatment of Morton's neuroma with minimally invasive distal metatarsal metaphyseal osteotomy and percutaneous release of the deep transverse metatarsal ligament showed significant improvement in pain and function with a low incidence of complications and a high rate of personal satisfaction.
(© 2022. The Author(s) under exclusive licence to SICOT aisbl.)
Databáze: MEDLINE
Externí odkaz: